Connect with us

Supplements

Dabo Swinney says Clemson may have given suspended players contaminated supplements – Sporting News

Published

on


The three Clemson football players suspended for the Tigers’ 2018 College Football Playoff run may have been issued performance-enhancing drugs (PEDs) by the team, coach Dabo Swinney said on Saturday.

In an interview with The Post and Courier (Charleston, S.C.), Swinney said the university is looking into how the suspended players — defensive lineman Dexter Lawrence, tight end Braden Galloway and offensive lineman Zach Giella — may have come into contact with the banned substance ostarine. Swinney said that includes the possibility the players ingested the substance from a team-issued supplement cleared by the NCAA.

MORE: Best bets to win national title next — besides Bama, Clemson

“Oh yeah, I mean, there’s a chance that it could come from anything,” Swinney told the Courier when asked if the ostarine came from a team-issued supplement. “They’re going to test everything and look at everything. And that’s the problem. As you really look at this stuff, it could be a contaminant that came from anything, that was something that was cleared and not a problem, and all of a sudden, it becomes there was something.”

Lawrence, Galloway and Giella have been suspended for the 2019 season as part of the NCAA’s ruling, though Lawrence has declared early for the 2019 NFL Draft.

The Post and Courier also reports school lawyers may take a “poor manufacturing process” defense when presenting the Clemson players’ case to the NCAA. They may cite the fact the team-issued supplement had been approved by the organization.

“You can research articles, there are a lot of times when things are cleared and end up having a contaminant in it because of where it was processed, the factory it came from, whether there were other things there, “Swinney said.

That said, the NCAA’s Dietary Supplements section of its website warns universities “there is no assurance of a product’s purity, safety or effectiveness” and that supplements may contain banned substances, regardless if they’re listed on the ingredients label, “due to contamination or poor manufacturing practices.”

Clemson on Friday received a 45-day extension by the NCAA to appeal the players’ suspensions.

Let’s block ads! (Why?)



Source link

Supplements

"You're Just Peeing Out a Lot of Money." This Is the Real Way You're Flushing Your Retirement Savings Down the Drain – MONEY

Published

on

By


| Money

this link is to an external site that may or may not meet accessibility guidelines.

Let’s block ads! (Why?)



Source link

Continue Reading

Supplements

FDA Sends Warning Letters on Dietary Supplements – Wall Street Journal

Published

on

By


The FDA has sent warning letters to companies marketing dietary supplements.


Photo:

Jacquelyn Martin/Associated Press

The U.S. Food and Drug Administration said it sent warning letters to 11 companies for marketing dietary supplements that don’t meet its guidelines.

The agency issued warnings to three companies for marketing dietary supplements containing phenibut, which is sometimes sold as a sleep aid or to treat anxiety. It said that phenibut doesn’t meet the statutory definition of a dietary ingredient, which is generally a vitamin, herb or other natural substance used to supplement the diet. 

A Wall Street Journal article last week on the $40 billion supplement industry said that phenibut, developed as a drug in the former Soviet Union, was being marketed as a “nootropic,” or brain supplement, in the U.S. A spokeswoman for the FDA said that the agency was already investigating phenibut.

The FDA also issued warnings to eight companies for marketing dietary supplements containing DMHA, a stimulant sometimes found in exercise and weight-loss supplements. The companies have 15 business days to inform the FDA of steps they will take to bring their products into compliance. That could include a decision to recall, reformulate or discontinue sales.

Supplements aren’t tightly regulated by the FDA like prescription drugs. Dietary-supplement manufacturers don’t need approval from the FDA before introducing their products to the market. The FDA has oversight for taking action against any misbranded supplement after it reaches the market.

The FDA said it is launching a new online tool to help warn consumers of ingredients that appear to be unlawfully marketed in supplements. The agency said the Dietary Supplement Ingredient Advisory List will help get cautionary information to the public more quickly before it issues any final determination. It is on the FDA website, and consumers can also sign up to receive updates and changes to the list.

Write to Anne Marie Chaker at anne-marie.chaker@wsj.com

Let’s block ads! (Why?)



Source link

Continue Reading

Supplements

New Tool Alerts Public to Unlawfully Marketed Dietary Supplement Ingredients – The Cardiology Advisor

Published

on

By


In an effort to better alert the public of unlawful ingredients in dietary supplements, the Food and Drug Administration (FDA) has created the Dietary Supplement Ingredient Advisory List, a new reference tool for consumers and manufacturers.

Available on the FDA website, the list includes ingredients that may not lawfully be included in dietary supplements. Consumers may wish to avoid supplements that include these ingredients as they may not fit the definition of a dietary ingredient or may require pre-market notification that was not submitted; inclusion in this list does not necessarily mean the ingredient poses a safety concern.

“It is important to note that the List is not exhaustive; it will always be a work in progress,” said Frank Yiannas, the FDA’s Deputy Commissioner for Food Policy and Response. “We expect the List will evolve as new ingredients are identified and others are removed.” In addition, the FDA will continue to communicate with the public regarding any safety concerns identified with new dietary supplement ingredients.

In a press statement, Yiannas also noted that the agency recently sent out warning letters to 8 companies that were marketing dietary supplements containing DMHA and 3 companies marketing supplements with phenibut; neither one of these currently meets the FDA’s definition of a lawful dietary ingredient. “We take these violations very seriously and stand ready to take enforcement action without further notice if the companies do not immediately cease distribution of the products,” said Yiannas. In February 2019, the FDA went after 17 companies selling unapproved and/or misbranded products (most sold as dietary supplements) claiming to prevent, treat, or cure Alzheimer disease and other serious disease and health conditions.

Consumers who wish to receive alerts related to updates to the Dietary Supplement Ingredient Advisory List can sign up here.

For more information visit FDA.gov.

Related Articles

This article originally appeared on MPR

Let’s block ads! (Why?)



Source link

Continue Reading

Trending